Oct. 24, 2024 — Researchers have found that semaglutide may lower the risk of Alzheimer's disease in people with type 2 diabetes ... Oct. 17, 2024 — Symptoms and disease progression of Rett ...
The GLP-1 RA semaglutide was associated with a 40%-70% reduced risk for first-time diagnosis of AD in patients with type 2 diabetes, real-world data show.